Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy (IRM Stéatose)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02085876 |
|
Recruitment Status : Unknown
Verified July 2013 by Centre Hospitalier Universitaire Dijon.
Recruitment status was: Not yet recruiting
First Posted : March 13, 2014
Last Update Posted : March 13, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This is a single centre prospective open-label, non-randomised pilot study whose aim is to identify MRI parameters to better evaluate inflammation and liver fibrosis and thus, in the near future, to avoid the need for liver biopsy.
To achieve this:
- The MRI study will be completed by adding two sequences: Measurement of T1 and multiecho T2*. The other data will be extracted from usual sequences.
- Part of the histological samples will be used for the weighted levels of fat and iron, and for the lipidomic study.
- Usual blood samples will be completed by samples for the serum library
| Condition or disease | Intervention/treatment |
|---|---|
| Overweight Type 2 Diabetes Obesity | Other: 2 additional MRI sequences Other: An additional blood sample |
| Study Type : | Observational |
| Estimated Enrollment : | 30 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy |
| Estimated Primary Completion Date : | February 2016 |
| Group/Cohort | Intervention/treatment |
|---|---|
| Patients requiring a liver biopsy |
Other: 2 additional MRI sequences Other: An additional blood sample |
- To determine a correlation coefficient > 0.80, alpha 0.05 and beta 0.20 between the MRI markers relevant. [ Time Frame: Baselines ]
- To determine the correlation between the unsaturated fat measurements and MRI Lipidomics Spectro analysis. [ Time Frame: Baselines ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients who have been informed about the research
- Patients with national health insurance cover
- Patients who are overweight (BMI > 25) or have type 2 diabetes suggesting a disturbance of hepatic enzymes (ASAT < 8 times normal values and ALAT > twice normal values) after a complete hepatopathy assessment
- Obese patients with a hepatic anomaly (steatosis) revealed by imaging or biological assessment (ASAT < 8 times normal values and ALAT > twice normal values) who are eligible for bariatric surgery and a preoperative liver MRI examination.
Exclusion Criteria:
- Non-corrected coagulation disorder.
- Patients aged over 80 years
- Patients aged less than 18 years
- Patients without legal protection
- Patients with a contra-indication for MRI (Pacemaker, intraocular metallic foreign body, weight>150kg)
- Patients without national health insurance cover
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02085876
| Contact: Samia HAMZA | 3 80 29 37 50 ext +33 | samia.hamza@chu-dijon.fr |
| France | |
| CHU de DIJON | |
| Dijon, France, 21079 | |
| Contact: Samia HAMZA 3 80 29 37 50 ext +33 samia.hamza@chu-dijon.fr | |
| Responsible Party: | Centre Hospitalier Universitaire Dijon |
| ClinicalTrials.gov Identifier: | NCT02085876 |
| Other Study ID Numbers: |
HAMZA APJ 2013 |
| First Posted: | March 13, 2014 Key Record Dates |
| Last Update Posted: | March 13, 2014 |
| Last Verified: | July 2013 |
|
patients present undergo bariatric surgery |
|
Overweight Body Weight |

